• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

“在 DMC 中,你必须保持冷静。”新生儿重症监护试验中数据监测委员会面临的挑战:BRACELET 研究的定性描述。

"You have to keep your nerve on a DMC." Challenges for Data Monitoring Committees in neonatal intensive care trials: Qualitative accounts from the BRACELET Study.

机构信息

Department of Medical Statistics, London School of Hygiene and Tropical Medicine, University of London, London, United Kingdom.

Birmingham Clinical Trials Unit, Institute of Applied Health Research, University of Birmingham, Edgbaston, Birmingham, United Kingdom.

出版信息

PLoS One. 2018 Jul 26;13(7):e0201037. doi: 10.1371/journal.pone.0201037. eCollection 2018.

DOI:10.1371/journal.pone.0201037
PMID:30048484
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6062057/
Abstract

BACKGROUND

Data Monitoring Committees (DMCs) are essential to the good conduct of many trials. Typically they comprise a small expert group which monitors safety, efficacy, progress and early outcome data as trials recruit. DMCs can recommend protocol revisions and early stopping of a trial. As DMC meetings usually consider unblinded interim data confidentially, their deliberations are seldom exposed to research scrutiny. Although there have been some case studies from trials from mixed specialties which offer insights into some of the common issues faced by DMCs, we have, however, little empirical information about the challenges faced within specific clinical settings.

METHODS

In-depth interviews with participants in the BRACELET Study on death and bereavement in neonatal intensive care trials produced qualitative accounts of experiences and views of a subgroup of 18 DMC members. These interviews explored views of DMC members in relation to the clinical context of neonatal intensive care and the conduct of neonatal intensive care trials.

RESULTS

Interviewees felt that an understanding of both the neonatal intensive care setting and population was crucial in a DMC. They considered the neonatal intensive care research population especially vulnerable, and that outcomes that included both death and severe disability raised particular challenges rarely faced in other settings. In exploring these key outcomes they were mindful of the need to meet high scientific standards and the needs of babies in the trials and their families. DMC members discussed particular difficulties around the composite outcome of death and severe disability, especially when mortality data were available long before data on longer term disability. While statistical stopping guidance is helpful, DMC members described decisions about stopping, revising or continuing a trial being informed by a wider set of considerations and discussions than a pre-set p value. These included potentially competing needs of current trial participants and future patients, and reflections on the nature of benefit and harm. Given their cognisance of the potential impact and consequences of the decisions made by DMCs in this setting of life, death, and disability, interviewees commonly used the imagery of bravery, and described DMCs either holding or losing their nerve.

CONCLUSIONS

DMCs for trials in other fields may also face difficult ethical trade-offs in monitoring composite outcomes. The experience from this sample of DMC members suggest that for neonatal intensive care trials there are some very specific challenges seldom faced elsewhere. The vulnerability of the population, and the different timescales for essential data becoming available to inform decisions, presented particular challenges. We suggest that it is important to consider the challenges raised in other settings to better understand the complex work of these committees and to prepare future generations of DMC members.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1095/6062057/96d2312f9913/pone.0201037.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1095/6062057/96d2312f9913/pone.0201037.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1095/6062057/96d2312f9913/pone.0201037.g001.jpg
摘要

背景

数据监测委员会(DMC)对于许多试验的良好进行至关重要。通常,它们由一个小的专家组组成,负责监测试验招募过程中的安全性、疗效、进展和早期结果数据。DMC 可以建议修改方案和提前终止试验。由于 DMC 会议通常会对未设盲的中期数据进行保密审议,因此其审议过程很少受到研究审查。虽然已经有一些来自混合专业领域的试验案例研究提供了 DMC 面临的一些常见问题的见解,但我们对特定临床环境中面临的挑战知之甚少。

方法

对 BRACELET 研究(新生儿重症监护试验中的死亡和丧亲)的参与者进行深入访谈,对 18 名 DMC 成员中的一个亚组产生了经验和观点的定性描述。这些访谈探讨了 DMC 成员对新生儿重症监护临床背景和新生儿重症监护试验进行的看法。

结果

受访者认为,对新生儿重症监护环境和人群的了解对于 DMC 至关重要。他们认为新生儿重症监护研究人群特别脆弱,并且包括死亡和严重残疾在内的结果提出了在其他环境中很少遇到的特殊挑战。在探讨这些关键结果时,他们注意到需要满足高科学标准以及试验中婴儿及其家庭的需求。DMC 成员讨论了死亡和严重残疾复合结果特别困难的问题,特别是当死亡率数据在长期残疾数据之前很久就可用时。虽然统计停止指导很有帮助,但 DMC 成员表示,停止、修改或继续试验的决定是由更广泛的考虑和讨论而不是预设的 p 值来决定的。这些考虑因素包括当前试验参与者和未来患者的潜在竞争需求,以及对受益和伤害性质的思考。鉴于他们意识到 DMC 在这种生命、死亡和残疾环境下做出的决策可能产生的影响和后果,受访者通常使用勇敢的形象,并描述 DMC 要么保持要么失去勇气。

结论

其他领域试验的 DMC 也可能在监测复合结果时面临艰难的伦理权衡。来自这些 DMC 成员的经验表明,对于新生儿重症监护试验,存在一些在其他地方很少遇到的特殊挑战。人群的脆弱性以及告知决策所需的关键数据可用的不同时间尺度带来了特殊挑战。我们建议,考虑在其他环境中提出的挑战对于更好地了解这些委员会的复杂工作以及为未来几代 DMC 成员做好准备非常重要。

相似文献

1
"You have to keep your nerve on a DMC." Challenges for Data Monitoring Committees in neonatal intensive care trials: Qualitative accounts from the BRACELET Study.“在 DMC 中,你必须保持冷静。”新生儿重症监护试验中数据监测委员会面临的挑战:BRACELET 研究的定性描述。
PLoS One. 2018 Jul 26;13(7):e0201037. doi: 10.1371/journal.pone.0201037. eCollection 2018.
2
Issues in data monitoring and interim analysis of trials.试验数据监测与中期分析中的问题。
Health Technol Assess. 2005 Mar;9(7):1-238, iii-iv. doi: 10.3310/hta9070.
3
Ethical preparedness of data monitoring committees (DMCs) to oversee international clinical trials: a qualitative descriptive study.数据监测委员会(DMC)监督国际临床试验的伦理准备情况:定性描述性研究。
BMJ Glob Health. 2024 Aug 25;9(8):e015233. doi: 10.1136/bmjgh-2024-015233.
4
Death, bereavement and randomised controlled trials (BRACELET): a methodological study of policy and practice in neonatal and paediatric intensive care trials.死亡、丧亲之痛与随机对照试验(BRACELET):新生儿及儿科重症监护试验政策与实践的方法学研究
Health Technol Assess. 2014 Jul;18(42):1-410. doi: 10.3310/hta18420.
5
Ethical Issues Faced by Data Monitoring Committees: Results from an Exploratory Qualitative Study.数据监测委员会面临的伦理问题:一项探索性定性研究的结果。
Ethics Hum Res. 2024 Nov-Dec;46(6):2-13. doi: 10.1002/eahr.500227.
6
Inside the Mind of the DMC: A Review of Principles and Issues with Case Studies.数据监测委员会的思维剖析:基于案例研究的原则与问题综述
Ther Innov Regul Sci. 2025 Mar;59(2):234-244. doi: 10.1007/s43441-024-00720-8. Epub 2024 Dec 17.
7
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
8
Enhancing trial integrity by protecting the independence of data monitoring committees in clinical trials.通过保护临床试验数据监测委员会的独立性来提高试验的完整性。
J Biopharm Stat. 2014;24(5):968-75. doi: 10.1080/10543406.2014.925719.
9
A systematic review of the reporting of Data Monitoring Committees' roles, interim analysis and early termination in pediatric clinical trials.系统评价儿科临床试验数据监测委员会的报告、中期分析和提前终止的作用。
BMC Pediatr. 2009 Dec 13;9:77. doi: 10.1186/1471-2431-9-77.
10
Independent academic Data Monitoring Committees for clinical trials in cardiovascular and cardiometabolic diseases.心血管和心脏代谢疾病临床试验的独立学术数据监测委员会。
Eur J Heart Fail. 2017 Apr;19(4):449-456. doi: 10.1002/ejhf.761. Epub 2017 Mar 8.

引用本文的文献

1
Ethical preparedness of data monitoring committees (DMCs) to oversee international clinical trials: a qualitative descriptive study.数据监测委员会(DMC)监督国际临床试验的伦理准备情况:定性描述性研究。
BMJ Glob Health. 2024 Aug 25;9(8):e015233. doi: 10.1136/bmjgh-2024-015233.
2
Experiences of the Data Monitoring Committee for the RECOVERY trial, a large-scale adaptive platform randomised trial of treatments for patients hospitalised with COVID-19.RECOVERY 试验数据监测委员会的经验,这是一项针对 COVID-19 住院患者治疗的大规模适应性平台随机试验。
Trials. 2022 Oct 18;23(1):881. doi: 10.1186/s13063-022-06824-6.
3
Importance and role of independent data monitoring committees (IDMCs) in oncology clinical trials.

本文引用的文献

1
Data Monitoring Committees - Expect the Unexpected.数据监测委员会——意料之外之事也要预料到。
N Engl J Med. 2016 Oct 6;375(14):1365-1371. doi: 10.1056/NEJMra1510066.
2
Reporting on data monitoring committees in neonatal randomised controlled trials is inconsistent.关于新生儿随机对照试验中数据监测委员会的报告并不一致。
Acta Paediatr. 2017 Jan;106(1):30-33. doi: 10.1111/apa.13593. Epub 2016 Oct 25.
3
Exploring the role and function of trial steering committees: results of an expert panel meeting.探索试验指导委员会的作用与功能:专家小组会议结果
重要性和独立数据监测委员会(IDMCs)在肿瘤临床试验中的作用。
BMJ Open. 2021 Oct 25;11(10):e047294. doi: 10.1136/bmjopen-2020-047294.
Trials. 2015 Dec 30;16:597. doi: 10.1186/s13063-015-1125-z.
4
Data monitoring committees for pragmatic clinical trials.实用性临床试验的数据监测委员会。
Clin Trials. 2015 Oct;12(5):530-6. doi: 10.1177/1740774515597697. Epub 2015 Sep 15.
5
Exploring the ethical and regulatory issues in pragmatic clinical trials.探讨实用临床试验中的伦理和监管问题。
Clin Trials. 2015 Oct;12(5):436-41. doi: 10.1177/1740774515598334. Epub 2015 Sep 15.
6
Developing training for Data Safety Monitoring Board members: A National Institute of Allergy and Infectious Diseases case study.为数据安全监测委员会成员开展培训:美国国立过敏与传染病研究所案例研究
Clin Trials. 2015 Dec;12(6):688-91. doi: 10.1177/1740774515591498. Epub 2015 Jul 7.
7
Trial Steering Committees in randomised controlled trials: A survey of registered clinical trials units to establish current practice and experiences.随机对照试验中的试验指导委员会:对注册临床试验单位的调查以确定当前实践和经验。
Clin Trials. 2015 Dec;12(6):664-76. doi: 10.1177/1740774515589959. Epub 2015 Jun 17.
8
Accounting for deaths in neonatal trials: is there a correct approach?新生儿试验中的死亡病例统计:是否存在正确的方法?
Arch Dis Child Fetal Neonatal Ed. 2015 May;100(3):F193-7. doi: 10.1136/archdischild-2014-306730. Epub 2015 Jan 20.
9
Independent data monitoring committees: preparing a path for the future.独立数据监测委员会:为未来铺平道路。
Am Heart J. 2014 Aug;168(2):135-41.e1. doi: 10.1016/j.ahj.2014.05.003. Epub 2014 May 15.
10
Death, bereavement and randomised controlled trials (BRACELET): a methodological study of policy and practice in neonatal and paediatric intensive care trials.死亡、丧亲之痛与随机对照试验(BRACELET):新生儿及儿科重症监护试验政策与实践的方法学研究
Health Technol Assess. 2014 Jul;18(42):1-410. doi: 10.3310/hta18420.